ChromoTek anti-CD16 recombinant VHH, FITC Plus

FITC-CD16 is a recombinant FITC Plus conjugated anti CD16 Nanobody (VHH) that targets IL6 in IF and FC applications, showing reactivity with human samples.
Cat No. FITC-CD16

Host/Type

Alpaca VHH

Reactivity

Human

Applications

IF, FC

Conjugate

FITC Plus

CD16 VHH, CD16 single domain antibody (sdAb), FCGR3, IGFR3, Fc-gamma R3, FcRIII

SKU/Size: 

-/ -

Freight/Packing: -

Quantity

Please visit your regions distributor:


Product Information

FITC-CD16 is a recombinant FITC Plus conjugated anti CD16 Nanobody (VHH) that targets IL6 in IF and FC applications, showing reactivity with human samples.

ApplicationsIF, FC
ReactivityHuman
ConjugateFITC Plus
TypeNanobody
ClassRecombinant
HostAlpaca
Affinity2 nM for CD16A, 4 nM for CD16B
Molecular Weight15.6 kDa
FormLiquid
Excitation/Emission Maxima Wavelengths500 nm / 520 nm
RRIDAB_3665974
Storage Buffer10 mM HEPES pH 7.0, 500 mM NaCl, 5 mM EDTA, 0.09% sodium azide
Storage ConditionStore at -20°C
Shippingblue ice
BackgroundCD16 is a 50-70-kDa low affinity Fc receptor found on the surface of natural killer cells, neutrophil polymorphonuclear leukocytes, monocytes and macrophages. CD16 mediates antibody-dependent cellular cytotoxicity (ADCC) and other antibody-dependent responses, such as phagocytosis. CD16 has been identified as Fc receptors FcγRIIIa (CD16a) and FcγRIIIb (CD16b), encoded by two nearly identical genes, FCGR3A and the FCGR3B.